SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load

The 2019 coronavirus disease (COVID-19) pandemic has demonstrated the importance of predicting, identifying, and tracking mutations throughout a pandemic event. As the COVID-19 global pandemic surpassed one year, several variants had emerged resulting in increased severity and transmissibility. Here...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin Skarzynski, Erin M. McAuley, Ezekiel J. Maier, Anthony C. Fries, Jameson D. Voss, Richard R. Chapleau
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Global Health, Epidemiology and Genomics
Online Access:http://dx.doi.org/10.1155/2022/6499217
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545871360688128
author Martin Skarzynski
Erin M. McAuley
Ezekiel J. Maier
Anthony C. Fries
Jameson D. Voss
Richard R. Chapleau
author_facet Martin Skarzynski
Erin M. McAuley
Ezekiel J. Maier
Anthony C. Fries
Jameson D. Voss
Richard R. Chapleau
author_sort Martin Skarzynski
collection DOAJ
description The 2019 coronavirus disease (COVID-19) pandemic has demonstrated the importance of predicting, identifying, and tracking mutations throughout a pandemic event. As the COVID-19 global pandemic surpassed one year, several variants had emerged resulting in increased severity and transmissibility. Here, we used PCR as a surrogate for viral load and consequent severity to evaluate the real-world capabilities of a genome-based clinical severity predictive algorithm. Using a previously published algorithm, we compared the viral genome-based severity predictions to clinically derived PCR-based viral load of 716 viral genomes. For those samples predicted to be “severe” (probability of severe illness >0.5), we observed an average cycle threshold (Ct) of 18.3, whereas those in in the “mild” category (severity probability <0.5) had an average Ct of 20.4 (P=0.0017). We also found a nontrivial correlation between predicted severity probability and cycle threshold (r = −0.199). Finally, when divided into severity probability quartiles, the group most likely to experience severe illness (≥75% probability) had a Ct of 16.6 (n = 10), whereas the group least likely to experience severe illness (<25% probability) had a Ct of 21.4 (n = 350) (P=0.0045). Taken together, our results suggest that the severity predicted by a genome-based algorithm can be related to clinical diagnostic tests and that relative severity may be inferred from diagnostic values.
format Article
id doaj-art-9def315f32984a029cd9d7d62652acc0
institution Kabale University
issn 2054-4200
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Global Health, Epidemiology and Genomics
spelling doaj-art-9def315f32984a029cd9d7d62652acc02025-02-03T07:24:27ZengWileyGlobal Health, Epidemiology and Genomics2054-42002022-01-01202210.1155/2022/6499217SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral LoadMartin Skarzynski0Erin M. McAuley1Ezekiel J. Maier2Anthony C. Fries3Jameson D. Voss4Richard R. Chapleau5Booz Allen HamiltonBooz Allen HamiltonBooz Allen HamiltonUS Air Force School of Aerospace MedicineUS Air Force Medical Readiness AgencyUS Air Force School of Aerospace MedicineThe 2019 coronavirus disease (COVID-19) pandemic has demonstrated the importance of predicting, identifying, and tracking mutations throughout a pandemic event. As the COVID-19 global pandemic surpassed one year, several variants had emerged resulting in increased severity and transmissibility. Here, we used PCR as a surrogate for viral load and consequent severity to evaluate the real-world capabilities of a genome-based clinical severity predictive algorithm. Using a previously published algorithm, we compared the viral genome-based severity predictions to clinically derived PCR-based viral load of 716 viral genomes. For those samples predicted to be “severe” (probability of severe illness >0.5), we observed an average cycle threshold (Ct) of 18.3, whereas those in in the “mild” category (severity probability <0.5) had an average Ct of 20.4 (P=0.0017). We also found a nontrivial correlation between predicted severity probability and cycle threshold (r = −0.199). Finally, when divided into severity probability quartiles, the group most likely to experience severe illness (≥75% probability) had a Ct of 16.6 (n = 10), whereas the group least likely to experience severe illness (<25% probability) had a Ct of 21.4 (n = 350) (P=0.0045). Taken together, our results suggest that the severity predicted by a genome-based algorithm can be related to clinical diagnostic tests and that relative severity may be inferred from diagnostic values.http://dx.doi.org/10.1155/2022/6499217
spellingShingle Martin Skarzynski
Erin M. McAuley
Ezekiel J. Maier
Anthony C. Fries
Jameson D. Voss
Richard R. Chapleau
SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load
Global Health, Epidemiology and Genomics
title SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load
title_full SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load
title_fullStr SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load
title_full_unstemmed SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load
title_short SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load
title_sort sars cov 2 genome based severity predictions correspond to lower qpcr values and higher viral load
url http://dx.doi.org/10.1155/2022/6499217
work_keys_str_mv AT martinskarzynski sarscov2genomebasedseveritypredictionscorrespondtolowerqpcrvaluesandhigherviralload
AT erinmmcauley sarscov2genomebasedseveritypredictionscorrespondtolowerqpcrvaluesandhigherviralload
AT ezekieljmaier sarscov2genomebasedseveritypredictionscorrespondtolowerqpcrvaluesandhigherviralload
AT anthonycfries sarscov2genomebasedseveritypredictionscorrespondtolowerqpcrvaluesandhigherviralload
AT jamesondvoss sarscov2genomebasedseveritypredictionscorrespondtolowerqpcrvaluesandhigherviralload
AT richardrchapleau sarscov2genomebasedseveritypredictionscorrespondtolowerqpcrvaluesandhigherviralload